ROIV logo

Roivant Sciences Ltd (ROIV)

Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies. Its clinical product candidates include IMVT-1402, a fully human monoclonal antibody targeting FcRn in development across several IgG-mediated autoimmune indications; mosliciguat, an inhaled sGC activa...

NASDAQHealthcareBiotechnologyUSA

Company Profile

Stock Code
ROIV
ISIN Code
BMG762791017
Currency
US Dollar (USD)
IPO Date
2021-10-01

Contact Information

Company Address
50 Broadway, London, United Kingdom, SW1H 0DB
Contact Phone
44 20 7400 3347
Company Website
https://roivant.com
Fiscal Year End
March

Financial Highlights

Market Capitalization
$999,999.99
Gross Profit (TTM)
$-999,999.99
Return on Assets (TTM)
-14.35%
EBITDA
$-999,999.99
Revenue (TTM)
$999,999.99